Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share - Schedule of potential common shares (Details)

v3.23.2
Net Loss Per Share - Schedule of potential common shares (Details) - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 3,885,324 4,444,221 3,885,324 4,444,221
Conversion of Convertible Preferred Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents   956,464   956,464
Warrants to Purchase Common Stock and Redeemable Convertible Preferred Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 853,330 853,330 853,330 853,330
PSUs, RSUs and Options to Purchase Common Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 2,448,661 2,051,094 2,448,661 2,051,094
Right to Receive Earnout Shares [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 583,333 583,333 583,333 583,333